Fat-cells were isolated from patients of body-mass indices (BMIs) ranging from 17.9 to 83.9 kg/m2. Isoprenalinestimulated cyclic AMP accumulation in cells prepared from obese subjects as compared with normal-weight subjects, was less sensitive to inhibition by the adenosine agonist A6-(phenylisopropyl)adenosine (PIA) (P = 0.047). The inhibition of 7,/-desacetyl-7,8-[y-(N-methylpiperazino)butyryl]-forskolin-stimulated adenylate cyclase by PIA in the presence of adenosine deaminase was also much attenuated in crude plasma membranes of adipocytes prepared from massively obese patients as compared with lean controls (P = 0.0143). This difference was probably not due to different cell size, because adenylate cyclase of crude plasma membranes of large adipocytes was actually more sensitive to PIA than was adenylate cyclase of membranes of smaller fat-cells co-isolated from the same individual. The stimulatory effect of PIA on glucose uptake in the presence of adenosine deaminase was depressed in adipocytes prepared from obese subjects and correlated with BMI at r = -0.626 (P = 0.007) at 100 nM-PIA. The adenosine receptors were studied by using the adenosine antagonist 1, (P = 0.047). The adenosine content of adipose tissue was higher in obese than in control subjects. These results demonstrate an attenuated response of cyclic AMP accumulation, adenylate cyclase and glucose uptake to adenosine in fat-cells prepared from obese subjects, and suggest that this change is at least partly due to changes in the amount of adenosine receptors, but not their affinity. The decreased receptor number could be due to higher adenosine content. A higher adenosine concentration in adipose tissue could explain why lipolysis is inhibited in situ in obesity, and the desensitization could explain the diminished response to adenosine analogues in isolated fat-cells.
INTRODUCTION
Morbid obesity is associated with profound metabolic changes. Studies on the turnover of labelled non-esterified fatty acids in plasma show that lipolysis, the release of non-esterified fatty acids and glycerol from adipocytes, is inhibited in vivo in obese subjects (Lillioja et al., 1986) . However, fat-cells isolated from obese donors and incubated in vitro have been shown to have an increased basal lipolysis and to display an attenuated response to inhibitors of cyclic AMP accumulation and lipolysis such as adenosine (Ohisalo et al., 1986) , clonidine and prostaglandins (Richelsen, 1988) . The molecular basis of this phenomenon has not been elucidated.
Lipolysis is accomplished by the enzyme hormone-sensitive lipase, which is activated by phosphorylation by protein kinase A, which, in turn, is activated by cyclic AMP. Thus lipolysis is controlled by receptors which inhibit or activate adenylate cyclase via the inhibitory and activating guanine-nucleotide-binding proteins (G-proteins) G, and G. (Gilman, 1987) . ,J-Adrenergic receptors activate, whereas az-adrenergic and adenosine Alreceptors inhibit, the cyclase. Adenosine is a short-lived nucleoside that exerts a local effect on adipocyte metabolism, inhibiting adenylate cyclase and thereby release of glycerol and non-esterified fatty acid (Schwabe et al., 1973; Ohisalo et al., 1984) . Adenosine also stimulates lipoprotein lipase activity (Ohisalo et al., 1981; Kern et al., 1988) and glucose uptake (Schwabe et al., 1973; Stoneham, 1989) . It was first reported by Ohisalo & Stouffer (1979) that the sensitivity of adipocytes to adenosine is modulated by thyroid hormones, cells from hypothyroid rats being more sensitive to inhibition of lipolysis by the adenosine-receptor agonist N6-(phenylisopropyl)adenosine (PIA). This altered sensitivity has been confirmed by several groups (Malbon et al., 1985; Woodward & Saggerson, 1986; Rapiejko & Malbon, 1987) . Changes in the sensitivity to adenosine have been reported since then in hypocortisolism (Saggerson, 1980) , with aging (Hoffman et al., 1984) , and both in human obesity (Ohisalo et al., 1986) and later in genetically obese rodents (Vannucci et al., 1989; Begin-Heick, 1990 ). Most investigators have suggested that alterations in G-protein levels or activity explain such changes. Clearly, the switch to more active lipolysis and weakened inhibitory responses could be due to any step from the affinities and amounts of receptors to the lipase itself, or to the phosphodiesterases that degrade cyclic AMP.
The aim of this work was to characterize the changes in the regulation of adipose-tissue metabolism in human obesity and to find the molecular basis of such changes.
MATERIALS AND METHODS Patients
Samples were taken from human subjects of body-mass index (BMI) ranging from 17.9 to 83.9 kg/m2. The Adenylate cyclase activity of fresh adipocyte crude membranes was assayed in a total volume of 500 ,l in the presence of as shown. After 20 min at 37°C, the incubation was terminated by boiling the tubes for 2 min. The boiled samples were then centrifuged and assayed for cyclic AMP as described above. Glucose uptake This was studied by the method of Kashiwagi et al. (1983) in cells isolated in the presence of 2 mM-glucose and then washed in glucose-free medium. The tracer was 580 nM-[14C]glucose. The incubations were done in a total volume of 400 ,ul in the presence of exogenous adenosine deaminase for 60 min under constant shaking at 37°C and were started by addition of the cells in 250 ,l. At 0 and 60 min, 150 1ul samples were taken and pipetted to plastic microcentrifuge tubes containing dinonyl phthalate, whose density is between that of fat-cells and water. The tubes were centrifuged in a Beckman Spinco 152 microcentrifuge as described by Gliemann & Sonne (1978) . The tubes were cut through the oil layer, and the upper parts containing the cells were counted for radioactivity.
Receptor-binding experiments
Adenosine Al-receptors were characterized by using the adenosine antagonist 1,3-[3H]dipropyl-8-cyclopentylxanthine ([3H]DPCPX) as the radioactive ligand and 10 /IM unlabelled PIA to measure non-specific binding. The assay was performed at 30°C in a total volume of 250 1u1 of 100 mM-NaCl/10 mmMgCl2/ 1 mM-EDTA/ 10 mM-Tris, pH 7.4. The assay mixture also contained 40 aM 5'-guanylyl imidodiphosphate. After 45 min of incubation, the mixtures were poured over glass-fibre filters under suction by a vacuum of 15 mmHg. The filters were washed with 2 x 5 ml of water, and the radioactivity associated with the filters was counted. Kd Small adipose-tissue pieces were excised from each patient at the beginning of the operation. The tissue pieces were -frozen immediately in liquid nitrogen and processed as described elsewhere (Ranta et al., 1985; Stoneham et al., 1988) . After freeze-drying of the samples, adenosine was measured by radioimmunoassay using an antiserum raised in a rabbit against laevulinic acid-(02',3-adenosine-acetal)albumin conjugate (Ranta et al., 1985 [PIA] (nM) Fig. 2 adenosine and deaminate and phosphorylate it. These problems can be overcome by adding adenosine deaminase to remove endogenous adenosine and using PIA, which is an adenosine Alreceptor agonist but is neither a substrate nor an inhibitor of adenosine deaminase. For studies of cyclic AMP levels, a time point first had to be chosen. Fig. 1 shows the cyclic AMP levels as a function of time in adipocytes stimulated by forskolin and isoprenaline. The levels rose rapidly and then remained constant, in contrast with reports on rat fat-cells, where the levels reach a peak and then decline. The levels remained constant for at least 80 min. Therefore the studies reported below were done at 60 min of incubation.
The inhibition of isoprenaline-stimulated cyclic AMP accumulation by PIA in adipocytes of four obese (BMI 46.4-81.0 kg/m2; mean 64.1) and six lean or normal-weight subjects (BMI 17.9-29.0 kg/M2; mean 23.7) at 60 min of incubation are shown in Fig. 2 . The effect of the nucleoside analogue was clearly more pronounced in the cells prepared from normal-weight donors (P = 0.047 with repeated-measures analysis of variance).
The differences in the levels of cyclic AMP in fat-cells from different subjects could be due to changes in the regulation or amount of adenylate cyclase or cyclic AMP phosphodiesterase. Studies with isolated plasma membranes revealed that adenylate cyclase activity stimulated by 7fl-desacetyl-7,f-[y-(Nmethylpiperazino)butyryl]-forskolin was more responsive to inhibition by PIA in membranes prepared from lean kg/M2; n = 4) as compared with membranes from obese (BMI 38.4-83.9 kg/M2; n = 6) patients (Fig. 3) . The dose-reponse curve was shifted to the right about 20-fold in membranes prepared from obese as compared with lean subjects. This difference was statistically significant at P = 0.0 14 (repeatedmeasures analysis of variance).
Since it has been suggested that cell size affects the hormone response of fat-cells directly (Arner et al., 1987) , we prepared cells of different sizes from the same subject. Crude membranes were isolated from both large (460-730 pl) and small (250-430 pl) fat-cells of three individuals with BMIs ranging from 27.1 to 30.1 kg/M2. The large cells were on average 1.8 times larger in volume than the corresponding small cells. Adenylate cyclase activity of the membranes was stimulated by 7/-desacetyl-7,/-[y-(N-methylpiperazino)butyryl]-forskolin in the presence of adenosine deaminase, and different concentrations of PIA were then added. The dose-response curves are summarized in Fig. 4 , which shows that membranes prepared from large cells were in fact more responsive to the nucleoside analogue than were those from smaller cells. [PIA] (pM) Fig. 4 . Inhibition of forskolin-stimulated adenylate cyclase activity by PIA in crude membranes isolated from large and small fat-cells of the same individual Fat-cells of different sizes were prepared from three patients as described in the Materials and methods section. Otherwise, the experiments were performed as in Fig. 3 . Forskolin-stimulated adenylate cyclase activity was designated 100 %. Vertical bars indicate S.E.M. l, Large cells; *, small cells. effect on glucose uptake was less in cells prepared from obese (BMI 32.5-52.8 kg/M2) as compared with normal-weight controls (BMI 20.0-31.2 kg/M2). Since all data points were not available on all the patients, a simple analysis of variance could not be applied, but the difference was statistically significant at P = 0.0077 at 100 nM-PIA (Student's two-tailed test of independent values). There was also a correlation between BMI and the effect of the adenosine analogue on glucose uptake at r = -0.626 and p = 0.007 (Fig. 6) . Adenosine receptors were studied by using [3H]DPCPX. This compound is an adenosine antagonist. The binding of DPCPX to human fat-cell membranes was rapid in the presence of 5'-guanylyl imidodiphosphate, and it was directly proportional to the amount of membrane protein used. Specific binding was approx. 50% at 1 nM-DPCPX. One binding experiment is displayed in Fig. 7 . Altogether 14 determinations of Kd values using samples from different patients were done. The K,, values were calculated by computer with a program that gives the same weight to each data point. There was no difference between the obese and lean groups. When computing the Bmax values, the geometric mean value of 3.3 nm was used as the Kd for all samples. The Bmax values of plasma-membrane adenosine receptors as a function of the BMI of the donor are displayed in Fig.  8 . Clearly, the receptor density calculated per mg of protein was lower in the obese than in the normal-weight subjects. There was a correlation at r = -0.539, which was statistically significant at P = 0.047 (regression analysis). The Bmax values of five normalweight kg/M2) and seven obese (BMI 38.6-81.0 kg/M2) subjects were 130 + 29 and 54 + 8 fmol/mg of protein, respectively (means+ S.E.M.). The difference was significant at P < = 0.0 18 (Student's two-tailed t test ofindependent values). 
DISCUSSION
These results confirm our earlier finding of an attenuated response to PIA as an inhibitor of isoprenaline-stimulated cyclic AMP accumulation in fat-cells isolated from obese donors as compared with normal cells (Ohisalo et al., 1986) . A similarly decreased response to inhibition via the a-adrenergic receptor in obesity was reported by Arner et al. (1987) , whereas the stimulatory response mediated via the,?-adrenergic receptor has been reported to be unchanged (Amer et al., 1987) or even decreased (Martin et al., 1990) . Therefore it seems that the alterations observed in the regulation of adipocyte metabolism in obesity can be explained by an altered inhibition of cyclic AMP accumulation, but not by enhanced stimulatory responses. The attenuated response to PIA in obesity was also observed with crude fat-cell membranes in the presence of an inhibitor of cyclic AMP phosphodiesterase. This suggests that a change in the activity of this enzyme cannot by itself explain the alterations in cells isolated from obese donors. The response in the isolated membranes was studied by using 7/3-desacetyl-7,/-[y-(Nmethylipiperazino)butyryl]-forskolin to stimulate adenylate cyclase directly independent of receptor systems. Therefore, the sluggish response of adenylate cyclase to inhibition by PIA cannot be due to high activity of the stimulatory arm of the regulatory system. This concept is further strengthened by the finding that glucose uptake in the presence of adenosine deaminase, but no other pharmacological agents, was less sensitive to stimulation by PIA in fat-cells from obese donors. This response is thought to be independent of cyclic AMP accumulation, though a G-protein seems to be involved (Kuroda et al., 1987) . The altered response could be explained by altered receptor number or affinity, an alteration in G-proteins or in the interaction between receptor and G-protein. Finally, it could be due to an alteration in the interaction of G-protein both with adenylate cyclase and with the second-messenger systems that lead to increased glucose uptake. An alteration occurring in the regulatory cascades before their point of divergence would be the simplest explanation for both changes, and this would place the molecular alteration at the receptor/G-protein level.
The present results show that the affinity of the adenosine receptor of crude adipocyte membranes for DPCPX is not affected by obesity. The receptor number as calculated per mg of protein was clearly decreased in obesity and negatively correlated with the BMI of the donor. Can this, then, be interpreted to mean that the attenuated sensitivity to adenosine is due to a decreased receptor density? It must first be noticed that we have previously reported that the amounts of both Gi and G. as calculated per mg of protein are lower in obesity (Ohisalo & Milligan, 1989) and that the observed relative difference was roughly the same as that reported here for adenosine receptors.
On the other hand, only a fraction of G, can be bound to adenosine receptors, and we have to wait until we can measure G-proteins bound to adenosine receptors before we can know the significance of the decrease in Gi. If Gi is present in excess, then a lowering of specific adenosine-receptor density could determine sensitivity to adenosine, despite changes in G-protein levels.
Cell size has been suggested to be a very important determinant of hormone-responsiveness (Arner et al., 1987) . Increased lipolysis in large fat-cells could, of course, be a way of keeping adipocytes from growing too large. Neither the present results with crude membranes prepared from adipocytes of different sizes from the same individual, nor the results on co-isolated small and large rat fat-cells reported by Francendese & DeMartinis (1985) , support this suggestion, but instead suggest that other factors are involved. One should notice, however, that fat-cells from massively obese donors are larger than the 'large' fat-cells in Fig. 4 , and cell size may become more important with very large cells. Unfortunately, very large fat-cells are fragile and could not be separated from smaller cells without excessive cell breakage.
The specific activity of adenylate cyclase was also lower in crude adipocyte membranes of obese individuals (see legend to Fig. 3 ). This was not due to different cell size alone, because the forskolin-stimulated maximal adenylate cyclase activity of membranes prepared from smaller cells was only 77+ 5 % (mean + S.E.M.) of that of membranes of co-isolated larger cells.
The adenosine content of adipose tissue was higher in obese than in normal-weight individuals, though the large variation in the values and problems in the interpretation of the data (Ranta et al., 1985) make it difficult to evaluate the significance of this finding. An elevated extracellular concentration of adenosine in obesity could explain the inhibition of lipolysis in situ and, through a desensitization mechanism, the decreased sensitivity of adipocytes from obese subjects to this nucleoside in vitro.
In summary, the present results show that both the inhibitory response of human adipocyte adenylate cyclase and the stimulatory response of glucose uptake to an adenosine analogue are attenuated in obesity, and suggest that this is not due to a change in cell size. The affinity of adenosine receptors was unaltered, but the number of receptors per mg of protein was low in membranes prepared from obese donors. These changes and the discrepancy between inhibited lipolysis in vivo and stimulated lipolysis in vitro could be explained by the observed increased adipose-tissue adenosine content. Vol. 279
